Search results

Institutionen för arkeologi och antikens historia bedriver forskning och utbildning inom fyra ämnen – antikens kultur och samhällsliv, arkeologi, historisk arkeologi och historisk osteologi. Institutionen har funnits i olika former vid Lunds universitet sedan 1805 men fick sin nuvarande sammansättning 2001. Sedan 2016 rymmer institutionen även Laboratoriet för digital arkeologi (DARKLab), en infraThe Department of Archaeology and Ancient History conducts research and education in four subjects – Classical Archaeology and Ancient History, Archaeology, Historical Archaeology and Historical Osteology. The department has existed in various forms at Lund University since 1805 but was given its current composition in 2001. Since 2016, the department also houses the Laboratory for Digital Archaeo

Markus Heidenblad is head of this facility.

Attila Frigyesi is Research Group Leader for this research group”

In this group we study how metastatic processes depend on suppression of the immune response and how the immune system actually instead promotes breast cancer metastasis. The research has a strong translational character with clinical collaborations and primary material as base in all projects. The focus is on immunosuppressive cell populations and metastatic processes in breast cancer. Understand

Håkan Axelson is Research Group Leader for this research group

Mikael Sigvardsson is Research Group Leader for this research group

Magnus Abrahamson is Research Group Leader for this research group

Cristian Bellodi is Research Group Leader for this research group

Markus Hansson is Research Leader for this research group

Fredrik Mertens is Research Group Leader for this reserach group

Stefan Schwartz is Research Group Leader for this research group

The Clinical Coagulation Research Unit in Malmö is managing several projects in the fields of thrombosis and bleeding disorders. Research in thrombosis includes epidemiological investigation into coagulation disorders, and research concerning different types and combinations of anticoagulant treatment. In the field of bleeding there are projects concerned with haemophilia, von Willebrand's disease

Cancer imaging is a growing field with screening programs for secondary prevention through early detection and advances in therapeutics as key drivers. Since primary prevention strategies are lacking for many types of cancers, imaging has a pivotal role in early detection, diagnosis and treatment response evaluation. Our research group has a long-standing experience especially in mammography scree

Nicholas Leigh is Research Group Leader for this research group

Björn Nilsson is Research Group Leader for this research group

Kristina Persson is the PI for this research group

Marianne Jansson is Resarch Group Leader for this research group

Translational research on prostate cancer: Identification of molecular targets for development of new therapies in chemo- and hormone resistant prostate cancer. This includes: 1) In vitro studies and animal models. 2) Development and validation of biomarkers in tissue, blood and urine including circulating tumor cells. 3) Biobanking. 4) Clinical studies on imaging biomarkers for prognosis, predict

In this group we study the tumor microenvironment in the context of colon cancer and with a focus on the inflammatory mediators leukotriene D4 (LTD4) and prostaglandins (PGE2) and their respective receptors. These mediators and their receptors are enriched in colon cancer cells and colon cancer tissues, which demonstrate there, contribute to tumor development and progression. Several of the observ

Christian Lindh is Research Group Leader for this research group